Logos Global Management »

Jatt Ii Acquisition Corp shares owned by Logos Global Management

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 100k 11.36

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Jatt Ii Acquisition Corp

Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Balyasny Asset Management
RA Capital Management
ADAR1 Capital Management
Franklin Resources
Atika Capital Management
Citadel Advisors
Farallon Capital Management
Braidwell
Nantahala Capital Management
Affinity Asset Advisors
TCG Crossover Management
Spruce Street Capital
Millennium Management

View all funds holding Jatt Ii Acquisition Corp